Acute Leukemia: Symptoms, Types and Urgent Care

Acute leukemia is a cancer of blood-forming cells that can progress quickly because immature abnormal white blood cells build up in the bone marrow and blood. Prompt medical evaluation is important, but modern care can include intensive treatment, targeted medicines and stem cell transplantation when appropriate.

Acute Leukemia Overview

Acute leukemia is a fast-growing cancer that begins in the bone marrow, the soft tissue inside bones where blood cells are made. It occurs when early blood-forming cells develop abnormal changes and multiply without maturing normally. These leukemia cells can crowd the marrow, reducing the production of healthy red blood cells, white blood cells and platelets.

The condition needs prompt specialist assessment because symptoms and blood-count changes may worsen over days or weeks. Treatment depends on the exact type of leukemia and its biological features, but many people can receive effective, carefully planned therapy. The two main categories are acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

Acute leukemia is different from chronic leukemia. “Acute” describes the rapid course and the presence of immature cells, often called blasts. It does not mean that every person has the same symptoms or outlook; prognosis varies substantially according to the leukemia subtype, genetic findings, age, general health and response to treatment.

What Is the Difference Between Leukemia and Acute Leukemia?

Leukemia is a broad term for cancers that affect blood-forming tissues, especially the bone marrow and blood. The disease is commonly classified by how quickly it develops—acute or chronic—and by the blood-cell lineage involved—myeloid or lymphoid.

Acute leukemia develops quickly and is driven mainly by immature abnormal cells. Without treatment, it can interfere with normal blood production rapidly. Chronic leukemias usually involve more mature cells and may develop more slowly, although they still require expert monitoring and treatment when indicated.

The main acute types are acute myeloid leukemia, which arises from myeloid precursor cells, and acute lymphoblastic leukemia, which begins in lymphoid precursor cells. A diagnosis requires laboratory testing because symptoms alone cannot reliably identify the type.

Symptoms and Early Signs of Acute Leukemia

Symptoms of acute leukemia commonly occur because the bone marrow is no longer making enough normal blood cells. Low red blood cells may cause tiredness, weakness, dizziness, pale skin or shortness of breath with usual activity. Low platelets can lead to easy bruising, pinpoint red or purple spots on the skin, nosebleeds, bleeding gums or heavier-than-usual menstrual bleeding.

When healthy infection-fighting white blood cells are reduced or do not work well, a person may experience frequent infections, fever, chills or infections that are difficult to clear. Some people also develop bone or joint pain, swollen lymph nodes, unexplained weight loss, reduced appetite, abdominal fullness or night sweats.

These symptoms are not specific to leukemia and can have many other causes, including infections, nutritional deficiencies and other medical conditions. However, persistent, worsening or unexplained symptoms should be discussed with a doctor. A complete blood count is often an important first test.

• Persistent tiredness or breathlessness
• Repeated or unusual infections and fever
• Easy bruising, prolonged bleeding or tiny red skin spots
• Bone pain, unexplained weight loss or drenching night sweats

Can You Provide an Overview of Acute Myeloid Leukemia?

Acute myeloid leukemia, or AML, is a form of acute leukemia that begins in myeloid cells. These cells normally develop into several types of blood cells, including red blood cells, platelets and some white blood cells. In AML, immature myeloid cells accumulate in the marrow and may enter the bloodstream.

AML is more common in adults than ALL, although it can occur at any age. It may arise without an identifiable cause, but risk can be influenced by older age, previous chemotherapy or radiation treatment, certain blood disorders, smoking and some inherited conditions. Having a risk factor does not mean that a person will develop AML.

Testing for chromosome and gene changes within leukemia cells is central to AML care. These results help clinicians classify the disease, estimate risk and select treatment. Depending on the situation, care may include chemotherapy, medicines that target particular molecular changes, lower-intensity drug combinations, supportive transfusions and bone marrow or stem cell transplantation.

AML is closely related to other disorders of blood-cell production, but it has its own diagnostic criteria and treatment approach. Specialist evaluation helps distinguish AML from conditions such as myelodysplastic syndromes, which may sometimes progress to AML.

How Serious Is Acute Leukemia?

Acute leukemia is a serious condition because it can progress rapidly and may cause dangerous infection, bleeding or severe anemia if untreated. It should be evaluated promptly by a hematologist or hematology-oncology team. Early recognition and supportive care are important even before a full treatment plan is finalized.

At the same time, seriousness should not be confused with inevitability. Outcomes differ widely between individuals and subtypes. Some acute leukemias respond very well to initial treatment, while others need more intensive or longer-term approaches. Genetic results, disease burden, response to early therapy and a person’s health all contribute to the outlook.

Care is usually delivered by a multidisciplinary team that can address leukemia-directed treatment as well as infection prevention, transfusions, fertility considerations, nutrition and emotional support. Discussing the specific diagnosis with the treating team provides the most meaningful information about expected treatment and outlook.

Diagnosis and Treatment Planning

Doctors usually begin with a medical history, physical examination and complete blood count with a review of the blood smear. If findings suggest acute leukemia, bone marrow aspiration and biopsy are generally needed to confirm the diagnosis and determine the type of leukemia.

Further testing may include flow cytometry, chromosome analysis and molecular genetic testing. These tests identify markers on leukemia cells and changes in genes or chromosomes. In certain situations, clinicians may also examine cerebrospinal fluid, perform imaging or assess heart, kidney and liver function before treatment.

Treatment is tailored to the subtype. It often has an initial phase aimed at achieving remission, followed by additional treatment intended to lower the chance of the leukemia returning. Options may include chemotherapy, targeted therapy, immunotherapy for selected conditions, radiation in limited circumstances and stem cell transplantation. People may also need transfusions, antibiotics or other supportive care during treatment.

Clinical decisions should be made with a qualified specialist, as treatment intensity must balance potential benefit with possible side effects and overall health. Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat acute leukemia for international patients.

Is AML the Deadliest Cancer?

It is not medically accurate to label AML as “the deadliest cancer.” Cancer outcomes are measured in different ways and vary by cancer type, stage, subtype, access to care and individual characteristics. AML is an aggressive blood cancer that requires urgent specialist treatment, but it is not a single uniform disease.

Some AML subtypes have treatment approaches that can be highly effective, while others carry a higher risk of relapse or may be harder to treat. Newer targeted medicines and improved supportive care have expanded treatment options for some people. Population-level survival figures cannot predict what will happen for one individual.

A hematology-oncology team can explain the particular AML subtype, laboratory findings and treatment goals. Asking about remission, relapse risk, available treatment choices and supportive-care needs can help patients and families understand the plan in practical terms.

When to Seek Medical Care

Medical care should be sought promptly for unexplained bruising or bleeding, persistent fever, repeated infections, marked fatigue, new shortness of breath, paleness or symptoms that are getting worse over a short period. These symptoms often have causes other than leukemia, but they deserve medical assessment, especially when several occur together.

Emergency care is appropriate for heavy or uncontrolled bleeding, severe shortness of breath, chest pain, confusion, fainting, a high fever in a person known to have low white blood cells, or signs of a severe infection. People already receiving leukemia treatment should follow their care team’s instructions about fever and urgent symptoms, as infections can require immediate treatment.

There is no proven way to prevent most cases of acute leukemia. Avoiding tobacco, limiting unnecessary exposure to harmful chemicals or radiation, and attending recommended follow-up after prior cancer treatment are sensible general health measures. These steps cannot eliminate risk, and no one should blame themselves for developing the condition.

Frequently asked questions